Welcome to CHAMP!
CHAMP Tools Quick Access
Quick Links: Study Resources
CITI Training Instructions (for consenters only)
CHAMP Recruitment Flyer (one-page pamphlet)
CHAMP Patient Eligibility Criteria and Workflow
REDCap Workflow (for research data collection)
CHAMP Consenting Workflow (in person and e-consent)
UW Consent Form (print for in person consent)
UW Consent Form – Spanish (print for in person consent)
UW E-Consent Form (for reference with patient online)
Instructions for How to Complete the E-Consent Form
Quick Links: Clinic Provider Resources
For password information, please contact Kat James.
PCP Champion Toolkit (information for all PCPs)
Intervention: Clinical Training Resources (pw protected)
Control: Clinical Training Resources (pw protected)
Intervention: BHCM Support Call Notes/Recording (pw protected)
Control: BHCM Support Call Notes/Recordings (pw protected)
Primary Care Provider Resources and Office Hours
Psychiatric Consultant Resources and Office Hours
Medication Assisted Treatment, with buprenorphine, methadone, or naltrexone, represents the gold-standard intervention for Opioid Use Disorder (OUD) and significantly reduces risk for overdose or death. However, only 20% of Americans with OUD received any formal or informal addiction treatment in the past year. Even in addiction treatment settings, only 32% of patients with OUD received Medication Assisted Treatment. Lack of access and engagement in Medication Assisted Treatment is driving poor OUD outcomes, especially in rural areas lacking specialty addiction services. To close this engagement gap, more patients with OUD need access to Medication Assisted Treatment in primary care settings.
The purpose of this trial is to test whether Collaborative Care (CoCM) that addresses both mental health disorders (MHD) and co-occurring opioid use disorder (OUD) can improve patient lives. This trial will also examine the effectiveness of screening for Opioid Use Disorder (OUD) and effectiveness of high or low sustainment support.
The trial will be conducted in 24 primary care clinics with existing CoCM programs or a commitment to initiate a CoCM program in the next 6 months. Clinics will be randomized to either adding OUD to their Collaborative Care program or maintaining Collaborative Care for mental health disorders only.
Our target is to enroll and treat 1200 eligible patients who screen positive for OUD and MHD over an 18-month period.